Medical Research Journals & Articles

Wednesday, September 8, 2010
Researchers: Pot helpful for some conditions.

Stick to the pipe, medical marijuana users: that’s the message from Canadian researchers

Monday, August 23, 2010

With protections for VA medical marijuana patients now secured by VHA DIRECTIVE 2010-035, some are wondering why the DEA continues to treat marijuana as a Schedule I drug.

Saturday, August 21, 2010

Fibromyalgia is a chronic pain syndrome of unknown etiology. The disease is characterized by widespread musculoskeletal pain, fatigue, and multiple tender points in the neck, spine, shoulders, and hips.

Cannabis Lab Work

Thursday, August 19, 2010
Cannabinoids  - THC, CBD, CBN.....
Cannabis products include marijuana, hashish, and hashish oil.
Tuesday, August 10, 2010
Getting to know one of the oldest marijuana related publications.

Thursday, August 5, 2010

Abstract (provisional)


ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and reduced responsiveness to standard therapies.

Friday, July 23, 2010

American Medical Association
Bureau of Legal Medicine and Legislation
Chicago, July 10, 1937
Hon. Pat Harrison
Chairman, Committee on Finance, United States Senate
Washington D.C.

SIR: I have been instructed by the board of trustees of the American Medical Association to protest on behalf of the association against the enactment in its present form of so much of H.R. 6906 as relates to the medicinal use of cannabis and its preparations and derivatives.

Friday, June 4, 2010
Thursday, May 27, 2010

As an $8.7-million state research effort comes to an end, investigators report that cannabis can significantly relieve neuropathic pain and reduce muscle spasms in MS patients. More research is urged.

Los Angeles Times - By John Hoeffel

With an innovative but little-known state program to study medical marijuana about to run out of money, researchers and political supporters said Wednesday the results show promise.

Sunday, February 7, 2010

by: Aaron Turpen

A systematic review conducted by The Global Neuroscience Initiative Foundation found that five of six controlled trials reported a reduction in spasticity and an improvement in mobility amongst multiple sclerosis patients using cannabis extracts.

The two researchers, Shaheen Lakhan and Marie Rowland from the Los Angeles-based foundation, searched for trials evaluating cannabis extracts. Specifically, they were looking for extracts known as delta 9 - tetrahydrocannabinol (THC) and cannabidiol (CBD). Their study was published in the December 2009 issue of BMC Neurology.

Syndicate content